Send2Press.com • Today is Saturday, July 04, 2009   A Member of the Neotrope News Network Neotrope®
Affordable Newswire Services and Targeted Distribution
Send2Press Newswire - Press Release Writing, Targeted News Distribution and Media Relations since 1983
 |  Daily News Desk  |  Journalist Tools  |  RSS Feeds  |  Send2Press® Home Page  |  Send2Press® Services  |  Press Release Distribution  |  Press Release Writing  |  About Send2Press  | 
Press Release Distribution
 Search Send2Press.com:
  Newswire Services
  Translate Page:    
PRESS RELEASE : U.S. and World News : Medical : Drugs and Pharmaceuticals News
Cypress Systems, Inc. Launches Cancer Prevention Health Campaign Using SelenoExcell(R)

Tue, 15 Apr 2008, 01:03:26 EDT
Edited by Carly Zander
Email this article Print this news article  Contact Info

FRESNO, Calif., April 15 (SEND2PRESS NEWSWIRE) -- Chairman and CEO, Paul Willis stated, "Just like his previous career at a large agribusiness company, Dr. Mark E. Whitacre has risen fast at Cypress Systems, Inc, last month being named the company's chief operating officer and president of operations." Now Cypress and Whitacre are focusing their energy on an aggressive cancer prevention campaign in order to get Americans-and people around the world-to consume a special type of selenium known as SelenoExcell(R). SelenoExcell(R) was found in a gold-standard human clinical trial to dramatically reduce colon, prostate, and lung cancers.

Caption: Dr. Mark E. WhitacreMark Whitacre is the subject of a motion picture to be filmed starting next month, titled, "The Informant," with box office mega star Matt Damon playing Whitacre. However, Whitacre's real mission in life and main passion for the future is focused on the role of selenium and SelenoExcell(R) as a cancer prevention agent. Cypress believes that with the anticipated media coverage related to the movie, there will be a window of opportunity to raise public awareness for SelenoExcell(R) and cancer prevention."

Awarded his Ph.D. at Cornell University, Dr. Whitacre did his research thesis on the biochemical role of selenium at the cellular level. His research was conducted jointly with a world-renowned selenium scientist, Dr. G. F. Combs, Jr. Dr. Whitacre today stated, "Although sadly underutilized, selenium has the potential to have the most profound impact upon dietary cancer prevention of any nutrient we know of today."

Cancer rates per 100,000 people are about the same as they were 40 years ago! According to the American Cancer Society, 565,650 people are expected to die this year due to cancer in the USA, and 1,437,180 people are expected to have cancer in 2008. "These cancer incidence and death rate due to cancer are unacceptable," said Dr. Whitacre. He further added, "Selenium acts as an active component of the important enzyme, glutathione peroxidase, which helps combat free radicals. Free radicals are part of the cause of many chronic diseases including cancer. Selenium plays a vital role in our natural defense system."

So far, no cancer preventive agents have gained FDA approval, save for a qualified claim for selenium. "This is strikingly odd since many cancer experts agree that the diet plays a strong role in cancer prevention", said Whitacre. But researchers have had a difficult time identifying which nutrients in a healthy diet, other than selenium, actually prevent cancer.

That question was largely answered in 1996 when the late Dr. Larry Clark, of the University of Arizona Cancer Research Center, and Dr. G.F. Combs, Jr., who was Professor at Cornell University at the time (and currently Director of the USDA in Grand Forks, ND), published results from the 10-year Nutritional Prevention of Cancer (NPC) Trial. The NPC Trial which was published in the December, 1996 Journal of the American Medical Association (JAMA), showed Cypress' SelenoExcell(R) brand selenium, taken as a dietary supplement at 200 micrograms per day, powerfully reduced the risk for many types of cancer (colon, lung and prostate) from 50%-63%.

Since then, Cypress Systems, Inc. has campaigned to promote SelenoExcell(R) as cancer preventive food ingredient. SelenoExcell(R) has met all of the requirements cancer researchers demand - safely proven in randomized, interventional, double blind, placebo-controlled, and long-term human trials. This is the "Gold Standard" of clinical research.

Savvy consumers have been seeking out the SelenoExcell(R) brand of selenium in health stores for over a decade. Today there is the opportunity to fortify foods using the same ingredient that was used in the 10-year study. SelenoExcell, selenium bound to an array of amino acids-such as cysteine and methionine - that form proteins, can be incorporated into bread, beverages, and other healthy foods. "Many types of selenium used in dietary supplements are unbound, inorganic, and are not the natural food form of selenium," said Mark Whitacre. "The biological availability of selenium is higher in organically-bound selenium," Whitacre added.

"We at Cypress Systems are placing our full energy behind taking this remarkable cancer prevention research to add this nutrient into normal diets. Our passion and our mission is to use this simple, safe, and inexpensive nutrient to lower cancer risk and prevent a horrible disease that has touched too many Americans' lives," said Whitacre.

More information: www.cypsystems.com.


NEWS SOURCE:  Cypress Systems, Inc.
Send2Press® is the originating wire service for this story.  Terms of Use




THE CONTENT OF THE ABOVE PRESS RELEASE WAS PROVIDED BY THE NEWS SOURCE, WHO IS SOLELY RESPONSIBLE FOR ITS ACCURACY. FOR QUESTIONS ABOUT THIS STORY CONTACT THE NEWS SOURCE AND NOT THIS WEBSITE (SEND2PRESS® NEWSWIRE).

Latest News from Send2Press Newswire:
U.S. and World News
» Narconon Graduate Successfully Recovers From Prescription Drug Abuse
» BONE FIRE Smokehouse Invites BBQ Fans to Cast their Votes on 'LIVE with Regis and Kelly'
» Spencer Pratt and Heidi Montag Discuss The New World Order and How 9/11 Was a Government Inside Job on Nationally Syndicated Alex Jones Show
» New Art Book Combines Chaos, God and Sex with Digital Imaging: 'Fractopia' by Christopher Simmons
» Financial Foundation Group Texas - A World without Breast Cancer
» No More 'Jon and Kate' Casualties
» Occupational Therapists Take Animal Therapies Beyond Special Equestrians
» New Web Site Helps Anyone Assist Humanity's Transformation Into a Global Brain
» Financial Foundation Group Texas - Building Futures
» Live Broadcast of Drug Rehab Graduation at Canadian Narconon
» Thanks to President Obama, Everyday is a Campaign
» ForeclosureDeals.com Does the Research for Its Clients
» LegalizeFerrets.org's YouTube Video Contest - Voting Starts June 29th through July 4th
» Pole-Wrap Launches Two New Products to Enhance a Home's Beauty
» MMDI Announces Agreement with Novation to Supply the Rebound HRD
» View All News Channels   » Press Release Services   » Home Page

Additional News on Similar Topics:
Drugs and Pharmaceuticals
» Potential Silver Bullet for Swine Flu and Most Common Infections Using Green Technology Patented in U.S. and Mexico
» Clinical Studies Validate Cancer Gene Delivery Platform: Landmark Publication Confirms Rexin-G Effectively Targets Metastatic Cancers and Improves Patient Survival
» Epeius Biotechnologies' Rexin-G Receives FDA Fast Track Designation for the Treatment of Pancreatic Cancer
» The World's Smallest Hero! Rexin-G, Targeted Therapy for Metastatic Cancers
» Rexin-G Controls Tumor Growth and Improves Survival in Chemotherapy-Resistant Sarcoma and Osteosarcoma: Phase I/II and Phase II Studies, ASCO 2009
» Beginners Luck, or Creative Artists of the First Rank? Epeius Biotechnologies Launches Rexin-G eBook Tutorial
» Rexin-G Shrinks Metastatic Tumors and Triples Survival Time in Chemotherapy-Resistant Pancreatic Cancer
» Silver Safety Pyramid Provides Guidelines for Safe Usage of Any Ionic Silver or Colloidal Silver Supplement
» Epeius Biotech Awarded Patents in Europe for Targeted Genetic Anti-Cancer Medicine: Company Expands Impressive Intellectual Property Estate
» Rexin-G Controls Tumor Growth and Improves Survival in Chemotherapy-Resistant Soft Tissue Sarcoma and Osteosarcoma
» Eularis Analyzes Pre-Launch Brand Planning with New Pharmaceutical Industry Report
» Rexin-G Returns to The Big Apple: Clinical Trials for Pancreatic Cancer and Breast Cancer Open in Manhattan
» SELECT TRIAL used Selenomethionine Instead of High-Selenium Yeast, SelenoExcell(R)
» Targeting Metastatic Cancer from the Inside: Epeius Biotech Reveals a New Generation of Tools for Medical Gene Delivery
» Eularis Releases First-Ever Study on ROI of Pre-Launch Named Patient Programmes
» View All News Channels   » Press Release Services   » Home Page

  Reader Resources
Share or Save Story with Bookmarks
Use one of the link buttons, below, to save, share, or bookmark this page for friends and/or future reference.
  Google  reddit Reddit  diigo Diigo
 delicious Delicious  Yahoo! Yahoo!  digg Digg
 blinklist Blinklist  blogmarks Blogmarks  Mixx! Mixx
Facebook  newsvine Newsvine
Subscribe Using Popular Social Tools
Use these tools to "subscribe" to the Send2Press Newswire feed of daily news content.
Follow Send2Press on Twitter  Follow on Twitter
Add News to Google   Add News to My Yahoo!
Add News to MyMSN   Add to My Wikio
  Choose RSS Feeds by News Topic

news services from Send2Press
  Subscribe to Weekly News Alert
  from Send2Press Newswire
Get a free weekly summary of our top newswire stories at the end of each week. Privacy protected and one-click removal in each summary. This is a "double opt-in" subscription, requiring clicking acceptance link in confirmation email.
 
Privacy Statement    How to Unsubscribe

Free News Feeds for Your Blog or Website!
Add news like this to your website with one click.
Simple Javascript copy-paste, or full RSS 2.0,
or Wordpress plugin.
Best of all, it's totally FREE!


Choose from city, state, or industry topics (over 300!). Most main topics updated weekly including business, entertainment and technology news.
CLICK HERE to LEARN MORE  

MuseWire

 
 U.S. and World News
 Advertising and Marketing
 Aerospace and Aviation
 Agriculture and Farming
 Apple, Mac, iPod and iPhone
 Auction and Online Auctions
 Auto and Motorsports
 Banking and Finance
 Beauty Products
 Boating, Marine and Maritime
 Business
 Communication Arts
 Company Profiles
 Computing
 Construction and Building
 Corporate Social Responsibility - CSR
 Defense and Military
 Education and Schools
 Electronics
 Employment, HR and Outsourcing
 Energy, Oil and Gas
 Entertainment
 Environment and Ecology
 Facilities and Building Maintenance
 Family, Parenting and Children
 Food and Beverages
 General Editorial
 Global Aid and Relief
 Government
 Green Business
 Health, Diet and Fitness
 Home and Garden
 HVAC Heating and Cooling
 Insurance
 Internet and Websites
 Jewelry and Diamond
 Legal and Law
 Manufacturing
 Medical
 Alternative Medicine 
 Biotechnology 
 Cosmetic Surgery 
 Dentistry 
 Devices and Research 
 Disabilities and 508 Compliance 
 Drug Rehabilitation 
 Drugs and Pharmaceuticals 
 Fertility and IVF 
 Hospitals and Nursing 
 Long Term Care 
 Medical and Health Products 
 Medical Business Services 
 Ophthalmology and Vision 
 Private Practice and Medical Groups 
 Surgery and Neurotechnology 
 Mining and Metals
 Mortuary and Cemetery
 NonProfit and Charities
 Plastics and Composites
 Police, Fire and Rescue
 Real Estate
 Regional Events
 Religion and Churches
 Restaurant, Hotel and Hospitality
 Safety and Security Solutions
 Sciences
 Sports and Activities
 Stamps, Coins and Collectables
 Taxes and Accounting
 Telecommunications and VoIP
 Theme Parks and Attractions
 Trade Shows, Fairs and Expos
 Transportation
 Travel and Tourism
 US and World History
 Veterinary and Pets
 
 U.S. State Newswires
 Alabama Business
 Alaska Business
 Arizona Business
 California Business
 Colorado Business
 Connecticut Business
 Delaware Business
 Florida Business
 Georgia Business
 Hawaii Business
 Idaho Business
 Illinois Business
 Indiana Business
 Iowa Business
 Kansas Business
 Kentucky Business
 Louisiana Business
 Maine Business
 Maryland Business
 Massachusetts Business
 Michigan Business
 Minnesota Business
 Mississippi Business
 Missouri Business
 Montana Business
 Nebraska Business
 Nevada Business
 New Hampshire Business
 New Jersey Business
 New Mexico Business
 New York Business
 North Carolina Business
 Ohio Business
 Oklahoma Business
 Oregon Business
 Pennsylvania Business
 Puerto Rico Business
 South Carolina Business
 South Dakota Business
 Tennessee Business
 Texas Business
 Utah Business
 Vermont Business
 Virginia Business
 Washington D.C. Business
 Washington State Business
 West Virginia Business
 Wisconsin Business
 
 Video News Releases
 
 World Newswires
 Australia Business
 Brazil Business
 Canada Business
 China Business
 Germany Business
 Italy Business
 Spain Business
 United Kingdom
Terms of Use and License
This "article" version of the issued press release is Copr. © 1983-2009 Neotrope/Send2Press. You may freely link to this article version of the press release or may use the release text as the basis for an original article or news posting. If the content is copied verbatim via a scraping or copy/paste method, the news item must be properly "attributed" to Send2Press® Newswire as the originating wire service for this story.
DISCLAIMER: the above press release content is believed accurate but not guaranteed, and is based on business news supplied by the source. The noted source is solely responsible for its accuracy. Financial/Stock news may contain forward looking statements. Neotrope/Send2Press (this website) makes no claims of accuracy or suitability for any purpose. Any opinions expressed by representatives of company(s) mentioned in news and profiles are solely those of the person indicated, and do not reflect any opinion or policy of Neotrope® or Send2Press. Your use of any information contained herein is done solely at your own risk, and you are fully responsible for using any information herein, or on sites mentioned or linked to in the article. All trademarks acknowledged.

REFERENCES: .
search engine marketing, and search engine optimization since 1995 - powered by ContextEngine(R) press release services, news distribution, press release writing, newswire services
MEDIA READS (by media and public, as of today): 2035 times (2 today, 22 this week, 13 this month, 542 this year)
Site Design and Content is Copr. © 1983 - 2009 Neotrope® - All rights reserved. Send2Press® is a reg. trademark and service mark of NEOTROPE.
Press Release Writing | About Send2Press | Meet Our Staff | Contact Us | Our Services | Help Desk | Legal | Privacy | How-To Articles | RSS Feeds | Headline Feeds | Podcast | PR News Channels | Top-10 News | Success Stories | PRTRax™ Reader Tracking | Targeted News Distribution | Internet Marketing Services | Order PR Services | Terms of Service (TOS)